Bioprocess Research and Development, Pfizer, Andover, MA 01810, USA.
Manufacturing Sciences and Technology, Global Technology and Engineering, Pfizer, Andover, MA 01810, USA; Manufacturing Intelligence, Global Technology and Engineering, Pfizer, Andover, MA, USA.
J Biotechnol. 2024 Jun 10;388:96-106. doi: 10.1016/j.jbiotec.2024.04.013. Epub 2024 Apr 18.
Bioprocess scale-up and technology transfer can be challenging due to multiple variables that need to be optimized during process development from laboratory scale to commercial manufacturing. Cell cultures are highly sensitive to key factors during process transfer across scales, including geometric variability in bioreactors, shear stress from impeller and sparging activity, and nutrient gradients that occur due to increasing blend times. To improve the scale-up and scale-down of these processes, it is important to fully characterize bioreactors to better understand the differences that will occur within the culture environment, especially the hydrodynamic profiles that will vary in vessel designs across scales. In this study, a comprehensive hydrodynamic characterization of the Ambr® 250 mammalian single-use bioreactor was performed using time-accurate computational fluid dynamics simulations conducted with M-Star computational fluid dynamics software, which employs lattice-Boltzmann techniques to solve the Navier-Stokes transport equations at a mesoscopic scale. The single-phase and two-phase fluid properties within this small-scale vessel were analyzed in the context of agitation hydrodynamics and mass transfer (both within the bulk fluid and the free surface) to effectively characterize and understand the differences that scale-down models possess when compared to their large-scale counterparts. The model results validate the use of computational fluid dynamics as an in-silico tool to characterize bioreactor hydrodynamics and additionally identify important free-surface transfer mechanics that need to be considered during the qualification of a scale-down model in the development of mammalian bioprocesses.
由于在从实验室规模到商业生产的工艺开发过程中需要优化多个变量,因此生物工艺放大和技术转让可能具有挑战性。细胞培养物在跨规模的过程转移过程中对关键因素非常敏感,包括生物反应器中的几何可变性、叶轮和曝气活动产生的剪切应力,以及由于混合时间增加而产生的营养物梯度。为了改进这些过程的放大和缩小,重要的是要充分表征生物反应器,以更好地了解培养环境中会出现的差异,特别是在跨规模的容器设计中会发生变化的流体动力学剖面。在这项研究中,使用 M-Star 计算流体动力学软件进行的时间精确计算流体动力学模拟对 Ambr® 250 哺乳动物一次性使用生物反应器进行了全面的流体动力学表征,该软件采用格子玻尔兹曼技术在介观尺度上求解纳维-斯托克斯输运方程。在搅拌流体动力学和传质(均在主体流体和自由表面内)的背景下分析了该小容器内的单相和两相流体特性,以有效地对放大缩小模型进行表征和理解与大尺寸模型相比,其具有的差异。模型结果验证了计算流体动力学作为一种用于生物反应器流体动力学特性表征的计算工具的使用,此外还确定了在哺乳动物生物工艺开发过程中对缩小模型进行资格认证时需要考虑的重要自由表面传递力学。